Gerard Ber's Net Worth
$2.01 Million
Who is Gerard Ber?
Gerard Ber has an estimated net worth of $2.01 Million. This is based on reported shares across multiple companies, which include Y-mAbs Therapeutics, Inc., Lantheus Holdings, Inc., and PROGENICS PHARMACEUTICALS INC.
SEC CIK
Gerard Ber's CIK is 0001762144
Past Insider Trading and Trends
2020 was Gerard Ber's most active year for acquiring shares with 6 total transactions. Gerard Ber's most active month to acquire stocks was the month of May. 2020 was Gerard Ber's most active year for disposing of shares, totalling 3 transactions. Gerard Ber's most active month to dispose stocks was the month of May. 2019 saw Gerard Ber paying a total of $0.00 for 72,393 shares, this is the most they've acquired in one year. In 2022 Gerard Ber cashed out on 1,277 shares for a total of $74,308.63, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Y-mAbs Therapeutics, Inc. (YMAB) Snapshot price: $13.17
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -30.99% | -722.00 |
$12.00 | -$8,664.00 | 1.61K |
Jun 10
| |||
Form 4
|
∞
| 2.33K |
—
|
—
| 2.33K |
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lantheus Holdings, Inc. (LNTH) Snapshot price: $54.86
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.68% | -629.00 |
$86.69 | -$54,525.90 | 36.72K |
May 8 - May 13
| |||
Form 4
| +7.59% | 2.63K |
—
|
—
| 37.35K |
May 9
| |||
Form 4
| +6.15% | 2.01K |
—
|
—
| 34.72K |
May 11
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
| -3.76% | -1.28K |
$58.19 | -$74,308.63 | 32.7K |
May 10
| |||
Form 4
| +6.86% | 2.18K |
—
|
—
| 33.98K |
May 6
| |||
Form 4
| +36.56% | 8.51K |
—
|
—
| 31.8K |
May 10
| |||
Form 4
| +4.79% | 1.06K |
—
|
—
| 23.29K |
Oct 1
| |||
Form 4
| +3.45% | 741 |
—
|
—
| 22.22K |
Aug 10
| |||
Form 4
|
∞
| 21.48K |
—
|
—
| 21.48K |
Jun 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PROGENICS PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -50.00K |
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||